TABLE 1 Europe Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 2 Europe Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antibody Drug Conjugates Market
TABLE 4 Acquisition & mergers – Antibody Drug Conjugates Market
TABLE 5 Approvals and trials– Antibody Drug Conjugates Market
TABLE 6 Europe Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 7 Europe Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 8 Europe Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 9 Europe Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 10 Europe Blood Cancer Market by Country, 2018 - 2021, USD Million
TABLE 11 Europe Blood Cancer Market by Country, 2022 - 2028, USD Million
TABLE 12 Europe Urothelial Cancer & Bladder Cancer Market by Country, 2018 - 2021, USD Million
TABLE 13 Europe Urothelial Cancer & Bladder Cancer Market by Country, 2022 - 2028, USD Million
TABLE 14 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 15 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 16 Europe Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 17 Europe Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 18 Europe Cleavable Linker Market by Country, 2018 - 2021, USD Million
TABLE 19 Europe Cleavable Linker Market by Country, 2022 - 2028, USD Million
TABLE 20 Europe Non-Cleavable Linker Market by Country, 2018 - 2021, USD Million
TABLE 21 Europe Non-Cleavable Linker Market by Country, 2022 - 2028, USD Million
TABLE 22 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 23 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 24 Europe Antibody Drug Conjugates Market by Country, 2018 - 2021, USD Million
TABLE 25 Europe Antibody Drug Conjugates Market by Country, 2022 - 2028, USD Million
TABLE 26 Germany Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 27 Germany Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 28 Germany Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 29 Germany Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 30 Germany Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 31 Germany Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 32 UK Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 33 UK Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 34 UK Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 35 UK Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 36 UK Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 37 UK Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 38 France Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 39 France Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 40 France Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 41 France Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 42 France Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 43 France Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 44 Russia Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 45 Russia Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 46 Russia Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 47 Russia Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 48 Russia Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 49 Russia Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 50 Spain Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 51 Spain Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 52 Spain Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 53 Spain Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 54 Spain Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 55 Spain Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 56 Italy Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 57 Italy Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 58 Italy Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 59 Italy Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 60 Italy Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 61 Italy Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 62 Rest of Europe Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 63 Rest of Europe Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 64 Rest of Europe Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 65 Rest of Europe Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 66 Rest of Europe Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 67 Rest of Europe Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 68 Key Information – Takeda Pharmaceutical Company Limited
TABLE 69 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 70 KEY INFORMATION – ASTRAZENECA PLC
TABLE 71 Key Information – GlaxoSmithKline PLC
TABLE 72 Key Information – Pfizer, Inc.
TABLE 73 key information – Astellas Pharma, Inc.
TABLE 74 Key Information – Gilead Sciences, Inc.
TABLE 75 Key Information – Seagen Inc.
TABLE 76 Key Information – ADC Therapeutics SA
TABLE 77 Key Information – Daiichi Sankyo Company, Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2018, May – 2022, Mar) Leading Players
FIG 5 Recent strategies and developments: Takeda Pharmaceutical Company Limited
FIG 6 Recent strategies and developments: Gilead Sciences, Inc.
Unique Offerings 